| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.8M | -25.1% | -53.6% |
| Cost of Revenue | $2.2M | -21.8% | -51.8% |
| Gross Profit | $1.6M | -29.2% | -55.8% |
| R&D Expense | $9.0M | +517.7% | — |
| SG&A Expense | $5.0M | +12.4% | +9.0% |
| Operating Income | -$3.3M | -57.4% | -277.1% |
| Interest Expense | $1.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.5M | +0.0% | +183.6% |
| Accounts Receivable | $990K | -32.5% | -65.1% |
| Inventory | $454K | -1.7% | +2.5% |
| Current Assets | $13.5M | -3.8% | +41.8% |
| Total Assets | $15.3M | -4.4% | +31.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.4M | — | — |
| Financing Cash Flow | $12.7M | — | — |
| — |
| Pre-tax Income | -$3.5M | +55.6% | -142.0% |
| Income Tax | $2K | +110.5% | -94.6% |
| Net Income | -$3.6M | +55.4% | -136.2% |
| EPS (Basic) | -$0.13 | +58.1% | -62.5% |
| EPS (Diluted) | -$0.13 | +58.1% | -62.5% |
| $15.8M |
| -2.6% |
| +20.6% |
| Long-term Debt | $6.6M | -13.8% | +558.1% |
| Total Liabilities | $23.5M | -6.6% | +47.5% |
| Stockholders' Equity | -$8.2M | +10.4% | -89.2% |